Smartstop Self Storage REIT (NYSE:SMA) Downgraded by BMO Capital Markets to Market Perform

Key Points

• BMO Capital Markets downgraded Smartstop Self Storage REIT from “outperform” to “market perform,” while maintaining a $38 price target—about 12.1% above the stock’s cited price. The broader analyst consensus remains “Moderate Buy,” with an average target of $36.64.
• Smartstop reported quarterly EPS of $0.20, missing the $0.49 consensus estimate, on revenue of $79.28 million. The stock opened at $33.90 and has traded between $29.41 and $39.77 over the past year.
• Company insiders sold 1,875 shares worth approximately $63,328 during the last quarter, while several major institutional investors—including Vanguard and T. Rowe Price—recently increased their holdings.

Smartstop Self Storage REIT (NYSE:SMA - Get Free Report) was downgraded by equities research analysts at BMO Capital Markets from an "outperform" rating to a "market perform" rating in a note issued to investors on Thursday, Marketbeat Ratings reports. They presently have a $38.00 price objective on the healthcare company's stock. BMO Capital Markets' price target would indicate a potential upside of 12.09% from the company's current price.

Several other research firms have also recently weighed in on SMA. Wells Fargo & Company reissued a "neutral" rating on shares of Smartstop Self Storage REIT in a report on Friday, July 24th. Robert W. Baird boosted their price target on Smartstop Self Storage REIT from $36.00 to $37.00 and gave the company an "outperform" rating in a research note on Monday, August 10th. Zacks Research raised Smartstop Self Storage REIT from a "strong sell" rating to a "hold" rating in a research report on Friday, May 8th. Weiss Ratings upgraded Smartstop Self Storage REIT from a "hold (c-)" rating to a "hold (c)" rating in a research note on Thursday, July 16th. Finally, Raymond James Financial initiated coverage on Smartstop Self Storage REIT in a report on Wednesday, July 15th. They issued a "strong-buy" rating and a $39.00 price objective for the company. Two investment analysts have rated the stock with a Strong Buy rating, four have issued a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $36.64.

Smartstop Self Storage REIT Trading Down 0.4%

NYSE SMA opened at $33.90 on Thursday. Smartstop Self Storage REIT has a 12 month low of $29.41 and a 12 month high of $39.77. The company has a current ratio of 5.28, a quick ratio of 5.28 and a debt-to-equity ratio of 0.89. The stock has a 50 day moving average of $33.70 and a 200-day moving average of $32.49. The company has a market cap of $1.88 billion, a PE ratio of 66.47 and a beta of 0.50.

Smartstop Self Storage REIT (NYSE:SMA - Get Free Report) last announced its quarterly earnings data on Wednesday, August 5th. The healthcare company reported $0.20 EPS for the quarter, missing analysts' consensus estimates of $0.49 by ($0.29). Smartstop Self Storage REIT had a net margin of 9.68% and a return on equity of 2.33%. The firm had revenue of $79.28 million during the quarter. Smartstop Self Storage REIT has set its FY 2026 guidance at 1.980-2.040 EPS. On average, equities research analysts anticipate that Smartstop Self Storage REIT will post 2 EPS for the current fiscal year.

Insider Transactions at Smartstop Self Storage REIT

In other Smartstop Self Storage REIT news, General Counsel Nicholas Look sold 1,025 shares of the business's stock in a transaction that occurred on Friday, August 14th. The shares were sold at an average price of $34.36, for a total transaction of $35,219.00. Following the completion of the transaction, the general counsel directly owned 588 shares in the company, valued at $20,203.68. The trade was a 63.55% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders have sold 1,875 shares of company stock valued at $63,328 over the last quarter. Company insiders own 5.70% of the company's stock.

Hedge Funds Weigh In On Smartstop Self Storage REIT

Several hedge funds and other institutional investors have recently modified their holdings of the business. Price T Rowe Associates Inc. MD boosted its stake in Smartstop Self Storage REIT by 13.7% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 5,913,679 shares of the healthcare company's stock valued at $182,972,000 after buying an additional 710,871 shares in the last quarter. Vanguard Group Inc. raised its stake in Smartstop Self Storage REIT by 122.2% during the fourth quarter. Vanguard Group Inc. now owns 3,576,922 shares of the healthcare company's stock worth $110,670,000 after acquiring an additional 1,967,321 shares in the last quarter. Principal Financial Group Inc. lifted its holdings in shares of Smartstop Self Storage REIT by 25.6% in the first quarter. Principal Financial Group Inc. now owns 2,596,133 shares of the healthcare company's stock worth $78,611,000 after acquiring an additional 528,974 shares during the last quarter. California State Teachers Retirement System lifted its holdings in shares of Smartstop Self Storage REIT by 3,067.5% in the second quarter. California State Teachers Retirement System now owns 2,206,295 shares of the healthcare company's stock worth $67,886,000 after acquiring an additional 2,136,641 shares during the last quarter. Finally, Wellington Management Group LLP boosted its stake in shares of Smartstop Self Storage REIT by 18.3% in the 4th quarter. Wellington Management Group LLP now owns 1,414,451 shares of the healthcare company's stock valued at $43,763,000 after purchasing an additional 218,386 shares in the last quarter.

Smartstop Self Storage REIT Company Profile

Symmetry Medical Inc (Symmetry) is a medical device solutions company, including surgical instruments, orthopedic implants, and sterilization cases and trays. The Company designs, develops and offers worldwide production and supply chain capabilities for these products to customers in the orthopedic industry, and other medical device markets (including but not limited to arthroscopy, dental, laparoscopy, osteobiologic, and endoscopy segments). It also manufactures specialized non-healthcare products, primarily in the aerospace industry.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source